By rray, 15 March, 2023 Note Activity of anti SARS CoV 2 specific monoclonal antibodies against currently circulating variants is significantly reduced tx w these agents is NOT recommended
By rray, 15 March, 2023 Determine risk for dz progression based on pt conditions COVID 19 vaccination status
By rray, 15 March, 2023 Consider adding baricitinib2 or tocilizumab if no rapid improvement in oxygenation w in 24h of tx